79
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Liver functions in silica-exposed workers in Egypt: possible role of matrix remodeling and immunological factors

, &

References

  • Brown T. Silica exposure, smoking, silicosis and lung cancer-complex interactions. Occup Med (Lond). 2009;59(2):89–95. [Review].
  • Schenker MB, Pinkerton KE, Mitchell D, Vallyathan V, Elvine-Kreis B, Green FH. Pneumoconiosis from agricultural dust exposure among young California farm workers. Environ Health Perspect. 2009;117(6):988–94.
  • Kalliny M, Bassyouni M. Immune response due to silica exposure in Egyptian phosphate mines. J Health Care Poor Underserved. 2011;22(4):91–109.
  • Shaikh S, Nafees A, Khetpal V, Jamali A, Arain A, Yousuf A. Respiratory symptoms and illnesses among brick kiln workers: a cross sectional study from rural districts of Pakistan. BMC Public Health. 2012;12:999.
  • Akgun M, Yilmazel UE, Araz O, Parker J. Prognosis of patients with silicosis due to denim sandblasting. Chest. 2012;141(3):831.
  • Calvert GM, Rice FL, Boiano JM, Sheehy JW, Sanderson WT. Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med. 2003;60:122–9.
  • Skurupiy VA, Nadeev AP, Karpov MA. Evaluation of destructive and reparative processes in the liver in experimental chronic granulomatosis of mixed (silicotic and tuberculous) etiology. Bull Exp Biol Med. 2010;149(6):685–8.
  • Slavin R, Swedo J, Brandes D, Gonzalez-Vitale J. Extrapulmonary silicosis: a clinical, morphologic, and ultrastructural study. Hum Pathol. 1985;16(4):393–412.
  • Aminian O, Sharifian SA, Mehrdad R. Humoral immune system alterations in silica exposed workers. Iran J Publ Health. 2008;37(3):142–5.
  • Persecă1 O, Cocârlă A. Nonspecific immunological aspects related to silicosis. J Prev Med. 2004;12(3–4):51–8.
  • Pernis B. Silica and the immune system. Acta Biomed. 2005;2:38–44.
  • Sternlicht M, Coussens LM, Vu TH, Werb Z. Biology and regulation of the matrix metalloproteinases. In: Clendeninn NJ, Appelt K, editors. Matrix metalloproteinase inhibitors in cancer therapy. Totowa, NJ: Humana Press Inc.; 2000. p. 1–37.
  • Vu TH, Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 2000;14:2123–33.
  • Scabilloni J, Wang L, Antonini J, Roberts J, Castranova V, Mercer R. Matrix metalloproteinase induction in fibrosis and fibrotic nodule formation due to silica inhalation. Am J Physiol Lung Cell Mol Physiol. 2005;288:L709–17.
  • Lim DH, Cho JY, Miller M, McElwain K, McElwain S, Broide D. Reduced peribronchial fibrosis in allergen-challenged MMP-9-deficient mice. Am J Physiol Lung Cell Mol Physiol. 2006;291:L265–71.
  • Gieling RG, Wallace K, Han YP. Interleukin-1 participates in the progression from liver injury to fibrosis. Am J Physiol Gastrointest Liver Physiol. 2009;296:G1324–31.
  • Mukherjee R, Colbath GP, Justus CD, Spinale FG. Spatiotemporal induction of matrix metalloproteinase-9 transcription after discrete myocardial injury. FASEB J. 2010;24(10):3819–28.
  • World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects [document on the Internet]. Revised by the 64th WMA General Assembly, Fortaleza, Brazil, October 2013 [cited 2014 January 13]. Available from: http://www.wma.net/e/policy/b3.html
  • International Labor office (ILO). Guidelines for the use of the ILO international classification of radiographs of pneumoconioses. Occupational safety and health Series No. 22 (ISBN 978-92-2-124542-1). Geneva: International Labour Office; 2011 [document on the internet]. Revised edition 2011 [cited 2014 January 13]. Available from: http://www.ilo.org/safework/info/publications/WCMS_168260/lang – en/index.htm
  • Zakim D, Boyer TD, Stolz A, Kaplowitz N. Biochemical tests for liver disease. In: Zakim D, Boyer TD, editors. Hepatology, 2nd edn. Philadelphia: WB Saunders; 1990. p. 637–57.
  • Seetharam S, Sussman NL, Komoda T, Alpers DH. The mechanism of elevated alkaline phosphatase activity after bile duct ligation in the rat. Hepatology. 1986;6(3):374–80.
  • Ostrow JD, Blanckaert N, Heirwegh KP. Analysis and preparation of bilirubins and biliverdins. In: Ostrow JD, editor. Bile pigments and jaundice. New York: Marcel Dekker; 1986. p. 31–79.
  • Burtis CA, Ashwood ER, Bruns DE, editors. Tietz textbook of clinical chemistry, 6th edn. Philadelphia: WB Saunders Company; 2008.
  • Lein M, Jung K, Nowak L, Schnorr D, Loening SA. Analytical aspects regarding the measurement of metalloproteinases. Ann NY Acad Sci. 1999;30(878):491–3.
  • Petra L, Van Kan HW, Verspaget A. ELISA assay for quantitative measurement of human immunoglobulins IgA, IgG, and IgM in nanograms. J Immunol Methods. 1983;57:51–7.
  • Hoshi K, Mizushima Y, Shoji Y, Kudo T, Ogita T. Enzyme-linked immunosorbent assay for measuring serum IgE. Experientia. 1980;36(9):11–22.
  • Smith MG, Williams R, Walker G, Rizzetto M, Doniach D. Hepatic disorders associated with liver-kidney microsomal antibodies. BMJ. 1974;2(5910): 80–4.
  • National Institute for Occupational Safety and Health, Manual of Analytical Methods, 4th edn, Method 7500, issue 4 silica, crystalline, by XRD (filter redeposition), 2003 [Document on the internet]. Revised edition 2003 March 15 [cited 2014 January 13]. Available from: www.cdc.gov/niosh/docs/2003-154/pdfs/7500.pdf
  • Cabinet of Priministry: 3rd edn. Prime Minister’s Decree No. 338 of 1995 Issuing the Executive Regulations of the Environment Law promulgated by Law No. 4 of 1994. Egypt. [cited January 2014 13] Available from: http://www.misr.gov.eg/english/laws/
  • National Institute for Occupational Safety and Health, NIOSH Hazard Review, Health effects of occupational exposure to respirable crystalline silica [document on the internet] DHHS (NIOSH) Publication No. 2002–12. [cited 2014 January 13]. Available from: http://www.cdc.gov/niosh/docs/2002-129/pdfs/2002-129.pdf
  • American Conference of Governmental Industrial Hygienists (ACGIH). Threshold limit values for chemical substances and physical agents and biological exposure indices. Cincinnati, OH: ACGIH; 2011.
  • Liou S, Chen YP, Shih WY, Lee CC. Pneumoconiosis and pulmonary function defects in silica-exposed fire brick workers. Arch Environ Health. 1996;51(3):227–33.
  • Concha-Barrientos M, Steenland K, Plunnet L. The contribution of occupational risks to global burden of diseases: summary and next steps. Med Lav. 2006;97(2):313–21.
  • Chen W, Liu Y, Wang H, Hnizdo E, Sun Y, Su L, et al. Long-term exposure to silica dust and risk of total and cause-specific mortality in Chinese workers: a cohort study. PLoS Med. 2012;9(4):e1001206.
  • Liu T, Li L, Fu C, Liu H, Chen D, Tang F. Pathological mechanisms of liver injury caused by continuous intraperitoneal injection of silica nanoparticles. Biomaterials. 2012;33:2399–407.
  • Kotoh K, Fukushima M, Horikawa Y, Yamashita S, Kohjima M, Nakamuta M, et al. Serum albumin is present at higher levels in alcoholic liver cirrhosis as compared to HCV-related cirrhosis. Exp Ther Med. 2012;3(1):72–5.
  • Ilahi I, Khan A, Ai M, Ullah U, Jawal A. Effects of stone dust exposure on some liver and kidney related serum parameters of stone crush plant workers. J Biol Life Sci. 2012;3(1):211–7.
  • Ogunbileje JO, Akinosun OM, Arinola OG, Akinduti P. Immunological classes (IgG, IgA, IgM and IgE) and liver function tests in Nigerian cement factory workers. Researcher. 2010;2(4):55–58.
  • Orman A, Kahraman A, Hamdullah C, Ellidokuz H, Serteser M. Plasma malondialdehyde and erythrocyte glutathione levels in workers with cement dust-exposure silicosis. Toxicology. 2005;207:15–20.
  • Mojiminiyi FB, Merenu IA, Ibrahim MT, Njoku CH. The effect of cement dust exposure on haematological and liver function parameters of cement factory workers in Sokoto, Nigeria. Niger J Physiol Sci. 2008;23(1–2):111–4.
  • Huang X. Iron, oxidative stress, and cell signaling in the pathogeneses of coal workers’ pneumoconiosis, silicosis, and asbestosis. Am J Biomed Sci. 2011;3(2):95–106.
  • Van Berlo D, Knaapen AM, Van Schooten FJ, Schins R, Albrecht C. NF-kappaB dependent and independent mechanisms of quartz-induced proinflammatory activation of lung epithelial cells. Part Fibre Toxicol. 2010;7:13.
  • Raghu G, Striker LJ, Hudson LD, Striker GE. Extracellular matrix in normal and fibrotic human lungs. Am Rev Respir Dis. 1985;131:281–9.
  • Perez-Ramos J, Segura-Valdez M, Vanda B, Selman M, Pardo A. Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis. Am J Respir Crit Care Med. 1999;160(4):1274–82.
  • Castranova V, Vallyathan V. Silicosis and coal workers pneumoconiosis. Environ Health Perspect. 2000;108:675–84.
  • Kossakowska AE, Edwards DR, Lee SS, Urbanski LS, Stabbler AL, Zhang CL, et al. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol. 1998;153:1895–902.
  • Tsutsumi M, Takase S, Urashima S, Ueshima Y, Kawahara H, Takada A. Serum markers for hepatic fibrosis in alcoholic liver disease: which is the best marker, type III procollagen, type IV collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase? Alcohol Clin Exp Res. 1996;20:1512–7.
  • Arthur M. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2000;279:G245–9.
  • Vigliani E, Pernis B. Immunological aspects of silicosis. Adv Tuberc Res. 1963;12:230–79.
  • Albuquereque de Castro H, Gimenes C, Lemle A. Immunoglobulins, complements and autoantibodies in 58 workers exposed to silica. J Bras Pneumol. 2004;30:201–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.